PULSE trial

We are pleased to announce our newest publication in the Cardiovascular Revascularization Medicine (March 2022) from the desk of Prof. Nicolas van Mieghem and Dr. Marcelo Bastos. 

Mechanical Circulatory Support is increasingly used in the context of high-risk percutaneous coronary intervention (PCI). The effect of the pulsatile iVAC 2L MCS on left ventricular loading conditions and myocardial oxygen consumption (MVO2) is unknown. In this publication, the Erasmus University Medical Centre & Kings College London showcase their clinical experiences with the iVAC 2L device and outline the impact on patients with advanced coronary artery disease at high to prohibitive operative risk in their practice. Please check the links for the full publication and a summary slidedeck.